Trade names of 'giperrou®' to 'Glewe' - electronic drug reference TALKDRUGS

Solution for intramuscular injection.
Collected crushed.
Solution for infusion.
Aerosol for topical application.

Capsules, 250 mg.

Raw materials - dry extract.

Ointment for topical and topical application 0,5%.

Solution for oral administration.

Tablets 4 mg, 8 mg, 16 mg, 32 mg.

Tablets 2.5 mg + 0.75 mg + 25 mg + 5 mg.

Eye drops 0.5%.

Unimed Pharma s.r.o. The Slovak Republic
homeopathic dissolving tablets
Coated tablets 150 mg. 10 tablets in a strip of aluminum foil. 1, 2 or 10 strips with instructions for use in cardboard
Capsules of 100 mg.
Cream for external use 0,1%.
Tablets of 50 mg.
Olainfarm, AO Latvia
Solution for intravenous administration.
Tablets are vaginal.
Tablets, film-coated, 120 mg and 180 mg.

Tablets, 1 mg, 3 mg, 4 mg.

Capsules with modified release 0.2 mg, 0.4 mg.

Lyophilized powder for the preparation of a solution for intravenous and intramuscular administration, 0.3 g, 0.6 g, 1.2 g and 1.8 g.

A solution for subcutaneous administration, 20 mg / ml.

Eye drops, 2%.

Rowecq Limited United Kingdom
Eye drops 0.005%.
Eye drops 2.5 mg / ml and 5 mg / ml.
Solution for intravenous and intramuscular injection 250 mg / ml.

Film coated tablets, 250 mg and 500 mg.

Solution for infusions 5 mg / ml.